DexCom (DXCM) Tops Q2 EPS by 7c; Raises Outlook

July 31, 2019 4:05 PM

DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.08, $0.07 better than the analyst estimate of $0.01. Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found